Creative Antibiotics AB (OSTO:CAS) EV-to-EBITDA : -18.81 (As of Jun. 22, 2024)

View and export this data going back to . Start your Free Trial

What is Creative Antibiotics AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Creative Antibiotics AB's enterprise value is kr205.86 Mil. Creative Antibiotics AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2013 was kr-10.94 Mil. Therefore, Creative Antibiotics AB's EV-to-EBITDA for today is -18.81.

The historical rank and industry rank for Creative Antibiotics AB's EV-to-EBITDA or its related term are showing as below:

OSTO:CAS's EV-to-EBITDA is not ranked ^*
in the industry.
Industry Median:
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-22), Creative Antibiotics AB's stock price is kr0.00. Creative Antibiotics AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2013 was kr0.000. Therefore, Creative Antibiotics AB's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Creative Antibiotics AB EV-to-EBITDA Historical Data

The historical data trend for Creative Antibiotics AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Antibiotics AB EV-to-EBITDA Chart

Creative Antibiotics AB Annual Data

Trend

Jun08

Jun09

Jun10

Dec11

EV-to-EBITDA

Creative Antibiotics AB Quarterly Data
	Jun08	Mar09	Jun09	Sep09	Dec09	Mar10	Sep10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Mar13
EV-to-EBITDA	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Creative Antibiotics AB's EV-to-EBITDA

For the subindustry, Creative Antibiotics AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Creative Antibiotics AB's EV-to-EBITDA Distribution in the Industry

For the industry and sector, Creative Antibiotics AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Creative Antibiotics AB's EV-to-EBITDA falls into.

Creative Antibiotics AB EV-to-EBITDA Calculation

Creative Antibiotics AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	205.864	/	-10.944
	=	-18.81

Creative Antibiotics AB's current Enterprise Value is kr205.86 Mil.
Creative Antibiotics AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-10.94 Mil.

Creative Antibiotics AB (OSTO:CAS) EV-to-EBITDA Explanation

Creative Antibiotics AB's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.00	/	0.000
	=	N/A

Creative Antibiotics AB's share price for today is kr0.00.
Creative Antibiotics AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.000.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Creative Antibiotics AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Creative Antibiotics AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.